Twist Bioscience Corp CEO Emily M. Leproust's Stock Transactions

On August 4, 2025, Emily M. Leproust, CEO and Director of Twist Bioscience Corp, sold 5,585 shares of common stock at a price of $28.364 per share. This sale was mandated by the company's equity incentive plans to cover tax withholding obligations related to the vesting of Restricted Stock Units. Following this transaction, Leproust owns 639,721 shares of common stock. Additionally, Leproust holds several employee stock options with varying expiration dates and exercise prices, including options that vested based on performance criteria met on December 19, 2022. These transactions reflect ongoing management of equity compensation and tax obligations.